Category Archives: Medical & Health Resources or Issues

Increasing Competition, Weakening FDA Oversight Could Reduce Drug Prices

David R. Henderson, a research fellow with the Hoover Foundation, and Charles L. Hooper, president of Objective Insights, wrote in the Washington Post “In Theory” section that more competition could reduce drug prices. By decreasing the FDA’s monopoly power over new drugs, … Continue reading

Posted in Medical & Health Resources or Issues | Leave a comment

Generic Drugs Sometimes Differ Dangerously from Branded Counterparts

Bloomberg News reports generic drugs are not necessarily comparable with their name-brand counterparts for two possible reasons. The first is that medicines are becoming increasingly complex, featuring specific release mechanisms that control how the body absorbs the specific mix of ingredients. … Continue reading

Posted in Medical & Health Resources or Issues | Leave a comment

Opioid Manufacturers Have Long History of “Deceptive” Advertising

The New York Daily News reported on the new marketing strategies of opioid makers, characterizing manufacturers and advertisers as “pill-peddling pitchmen” who “launched a campaign that became a multi-billion dollar success – and, critics say, an unmitigated national disaster.” Beginning with … Continue reading

Posted in Medical & Health Resources or Issues | Leave a comment

US Cigarette Companies Agree to Run “Corrective Statements” Beginning in November

The Richmond (VA) Times-Dispatch reports Altria, Reynolds American, and other U.S. cigarette companies reached an agreement with the U.S. Department of Justice on Monday to run “corrective statements” on TV and in newspapers beginning in late November. Among the statements is: … Continue reading

Posted in Medical & Health Resources or Issues | Leave a comment

Juno Ends CAR-T Drug Development After Patient Deaths

Reuters reports that Juno Therapeutics “said it decided to shut down development of an experimental leukemia treatment from a highly promising new class of immunotherapy following an investigation into toxicity that led to a handful of patient deaths.” Reuters explains that … Continue reading

Posted in Medical & Health Resources or Issues | Leave a comment

Two Ohio Cities File Lawsuits Against Opioid Drugmakers and Distributors

The Columbus (OH) Dispatch reports Ohio cities Dayton and Lorain have joined the state’s Attorney General Mike DeWine in suing several manufacturers of opioid pain relievers, including Allergan. Unlike DeWine’s suit, Dayton has also sued drug distributors including Cardinal Health and … Continue reading

Posted in Medical & Health Resources or Issues | Leave a comment

How Do Doctors Stay in Compliance with Medical Licensing Laws?

Medical professionals are required to adhere to the code of conduct of their practice and follow the law strictly to the letter. For you to qualify to render medical services, you are required to get a medical practicing license from … Continue reading

Posted in Medical & Health Resources or Issues | Leave a comment

Most Off-Label Use of Antidepressants May Not Be Supported by Evidence

AFP reports that “most off-label use of antidepressants is not backed by evidence that the” medications “will work as intended…say” researchers. HealthDay reports that investigators came to this conclusion after analyzing approximately “100,000 antidepressant prescriptions issued in Quebec, Canada, between 2003 and … Continue reading

Posted in Medical & Health Resources or Issues | Leave a comment

Zimmer Biomet Recalls Spinal Fusion Stimulators Due to Harmful Chemicals

Mass Device reports that the Food and Drug Administration “released information on a Zimmer Biomet (NYSE: ZBH) recall of select SpF Plus-Mini and SpF XL IIB implantable spinal fusion stimulators over issues with potentially harmful chemicals which could be toxic to … Continue reading

Posted in Medical & Health Resources or Issues | Leave a comment

Class Action Targets Prices, Rebates for Diabetes Treatments

Fierce Pharma reports that Novo Nordisk and pharmacy benefit manager OptumRx are facing a class action lawsuit over an alleged “conspiracy to raise the price of diabetes medicines so that the drugmaker could pay rebates to the PBM.” The lawsuit claims … Continue reading

Posted in Medical & Health Resources or Issues | Comments Off on Class Action Targets Prices, Rebates for Diabetes Treatments